Attributable Mortality of Nosocomial Acinetobacter Bacteremia
- 1 March 2007
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 28 (3) , 293-298
- https://doi.org/10.1086/512629
Abstract
Objective.: To determine the attributable mortality and outcome of nosocomial Acinetobacter bacteremia.Design.: Matched, retrospective cohort study.Setting.: Large, university-based, tertiary care center.Patients.: Of 219 patients with nosocomial Acinetobacter bacteremia identified by prospective surveillance during a 3-year period, 52 met the criteria for the study and were matched to a control patient by age, sex, primary and secondary diagnosis, operative procedures, and date of admission.Results.: A 100% success rate was achieved in the proportion of case patients and control patients matched for the compared criteria, except for major operative procedures (88%) and the presence of an important secondary underlying disease (54.5%). Twenty-nine (55.7%) of the case patients died, compared with 10 (19.2%) of the control patients (P < .001). The attributable mortality was 36.5% (95% CI, 27%-46%) and the risk ratio for death was 2.9 (95% CI, 1.58-5.32). In a multivariate survival analysis, older age, mechanical ventilation, renal failure, and Acinetobacter bacteremia (hazard ratio [HR], 4.41; 95% confidence interval [CI], 1.97-9.87; P < .001) were found to be independent predictors of mortality. There was a trend for a longer median duration of hospitalization among case patients, compared with control patients (11.5 vs. 6.5 days; P = .06). Three isolates were resistant to all but 1 antibiotic tested (colistin), and 45 isolates (86.5%) were resistant to 4 or more different antibiotic classes.Conclusions.: When adjusted for risk-exposure time and severity of disease at admission, nosocomial Acinetobacter bacteremia is associated with mortality in excess of that caused by the underlying diseases alone.Keywords
This publication has 21 references indexed in Scilit:
- Nosocomial Bloodstream Infections in US Hospitals: Analysis of 24,179 Cases from a Prospective Nationwide Surveillance StudyClinical Infectious Diseases, 2004
- Attributable Mortality of Nosocomial Candidemia, RevisitedClinical Infectious Diseases, 2003
- Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort studyIntensive Care Medicine, 2003
- Efficacy of Colistin versus β-Lactams, Aminoglycosides, and Rifampin as Monotherapy in a Mouse Model of Pneumonia Caused by Multiresistant Acinetobacter baumanniiAntimicrobial Agents and Chemotherapy, 2002
- Attributable Morbidity and Mortality of Catheter-Related Septicemia in Critically Ill Patients: a Matched, Risk-Adjusted, Cohort StudyInfection Control & Hospital Epidemiology, 1999
- Risk Factors for Nosocomial Bloodstream Infections Due to Acinetobacter baumannii: A Case‐Control Study of Adult Burn PatientsClinical Infectious Diseases, 1999
- Risk Factors and Outcome of Nosocomial Infections: Results of a Matched Case-control Study of ICU PatientsAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Nosocomial Bacteremia in Critically Ill Patients: A Multicenter Study Evaluating Epidemiology and PrognosisClinical Infectious Diseases, 1997
- Bacteremia Due to Acinetobacter baumannii: Epidemiology, Clinical Findings, and Prognostic FeaturesClinical Infectious Diseases, 1996
- Antimicrobial susceptibility of Acinetobacter speciesAntimicrobial Agents and Chemotherapy, 1993